Recent Updates
Recently added Catalysts
MYGN Positive Sentiment Score: 70/100

Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference

Tuesday, January 6, 2026 1 min read
Key Takeaway: Myriad Genetics, a leader in molecular diagnostics, announced that its CEO, Sam Raha, will present at the 44th Annual J.P. Morgan Healthcare Conference on January 14. The presentation will be available via live webcast, showcasing the company's advancements in precision medicine and diagnostic testing. This event underscores Myriad's commitment to improving patient care.
Price reaction · baseline $6.14 (2026-01-05 close) · hit pre-market · clean, no other MYGN news in the window
day 0 close
+6.2%
day 1 · peak
+8%
day 3
+7.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Myriad Genetics is recognized as a leader in molecular diagnostic testing.
  • The presentation at a prestigious conference highlights the company's prominence.
  • The webcast allows broader access to their insights and developments.

Full Press Release Details

SALT LAKE CITY, Jan. 05, 2026 (GLOBE NEWSWIRE) --Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Sam Raha, president and CEO, will present at the 44thAnnual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 14, at 5:15 pm PT (8:15 pm ET).
The presentation will be available through a live webcast and archived atinvestor.myriad.com.
About Myriad GeneticsMyriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and offers molecular tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care and lower healthcare costs. For more information, visitwww.myriad.com.

Investor ContactMatt Scalo(801) 584-3532IR@myriad.com

Media ContactKate Schraml(224) 875-4493PR@myriad.com

Frequently Asked Questions

When will Myriad Genetics present at the conference?

Myriad Genetics will present on January 14 at 5:15 pm PT.

Who is presenting for Myriad Genetics?

Sam Raha, the president and CEO, will present at the conference.

Where can I watch the presentation?

The presentation will be available via a live webcast at investor.myriad.com.

What does Myriad Genetics specialize in?

Myriad Genetics specializes in molecular diagnostic testing and precision medicine.

Tags: MYGN Viatris Investor Conferences Healthcare Myriad Genetics J.P. Morgan Conference molecular diagnostics precision medicine Sam Raha
Last updated: Jan 6, 2026

Biotech snapshot

Cash runway
$124M liquidity · $5M/mo burn
~21 mo
Low dilution risk
Lead asset
SKB264Phase 2
Solid Tumor →